Epilepsy Talk

Senators Thrash BIG Pharma CEOs for Pricing Drugs Higher in the U.S.

February 12, 2024
Leave a Comment

One in four Americans can’t afford their prescription drugs.

No big surprise.

Price are higher than any other wealthy nation.

Here are some stunning examples: Johnson & Johnson’s arthritis drug Ustekinumab (Stelara) costs $79,000 in the U.S.

But it costs $20,000 in Canada and $12,000 in France.

Posted in Epilepsy, Medication Issues, News
Tags: , , , , , ,

    About the author

    Phylis Feiner Johnson

    Phylis Feiner Johnson

    I've been a professional copywriter for over 35 years. I also had epilepsy for decades. My mission is advocacy; to increase education, awareness and funding for epilepsy research. Together, we can make a huge difference. If not changing the world, at least helping each other, with wisdom, compassion and sharing.

    View Full Profile →

    To receive Epilepsy Talk articles FREE, simply go to the bottom of the right column, enter your email address and click on "Follow"

    Join 3,108 other subscribers
    Follow Epilepsy Talk on WordPress.com